Build Your Comparison

Side-by-side financial analysis
FLGC logo
FLGC
CGC logo
CGC
JPM logo
JPM
TLRY logo
TLRY
ACB logo
ACB
Try popular comparisons:

Stock Comparison

FLGC vs CGC vs JPM vs TLRY vs ACB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FLGC
Flora Growth Corp.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$88M
5Y Perf.-99.8%
CGC
Canopy Growth Corporation

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$372M
5Y Perf.-99.6%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+82.8%
TLRY
Tilray Brands, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$551M
5Y Perf.-52.8%
ACB
Aurora Cannabis Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$181M
5Y Perf.-96.0%

FLGC vs CGC vs JPM vs TLRY vs ACB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FLGC logoFLGC
CGC logoCGC
JPM logoJPM
TLRY logoTLRY
ACB logoACB
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericBanks - DiversifiedDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic
Market Cap$88M$372M$908.57B$551M$181M
Revenue (TTM)$14M$312M$280.33B$1.17B$311M
Net Income (TTM)$-120M$-367M$57.05B$-2.95B$-75M
Gross Margin43.3%24.9%60.0%28.0%56.6%
Operating Margin-30.7%-33.0%25.9%-266.0%0.3%
Forward P/E14.6x
Total Debt$54M$325M$942.38B$451M$24M
Cash & Equiv.$6M$509M$343.34B$304M$113M

FLGC vs CGC vs JPM vs TLRY vs ACBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FLGC
CGC
JPM
TLRY
ACB
StockMay 21Mar 26Return
Flora Growth Corp. (FLGC)1000.2-99.8%
Canopy Growth Corpo… (CGC)1000.4-99.6%
JPMorgan Chase & Co. (JPM)100182.8+82.8%
Tilray Brands, Inc. (TLRY)10047.2-52.8%
Aurora Cannabis Inc. (ACB)1004.0-96.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: FLGC vs CGC vs JPM vs TLRY vs ACB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 4 of 6 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Canopy Growth Corporation is the stronger pick specifically for growth and revenue expansion. TLRY also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
FLGC
Flora Growth Corp.
The Healthcare Pick

FLGC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
CGC
Canopy Growth Corporation
The Growth Play

CGC is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 79.8%, EPS growth 84.1%, 3Y rev CAGR 13.2%
  • 79.8% revenue growth vs FLGC's -75.6%
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.87, yield 1.8%
  • 481.2% 10Y total return vs TLRY's -78.9%
  • 20.4% margin vs FLGC's -8.3%
  • Beta 0.87 vs FLGC's 3.12
Best for: income & stability and long-term compounding
TLRY
Tilray Brands, Inc.
The Momentum Pick

TLRY ranks third and is worth considering specifically for momentum.

  • +11.3% vs FLGC's -74.3%
Best for: momentum
ACB
Aurora Cannabis Inc.
The Defensive Pick

ACB is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.64, Low D/E 4.7%, current ratio 5.94x
  • Beta 1.64, current ratio 5.94x
Best for: sleep-well-at-night and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthCGC logoCGC79.8% revenue growth vs FLGC's -75.6%
Quality / MarginsJPM logoJPM20.4% margin vs FLGC's -8.3%
Stability / SafetyJPM logoJPMBeta 0.87 vs FLGC's 3.12
DividendsJPM logoJPM1.8% yield; 15-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)TLRY logoTLRY+11.3% vs FLGC's -74.3%
Efficiency (ROA)JPM logoJPM1.3% ROA vs FLGC's -192.1%, ROIC 4.5% vs -5.5%

FLGC vs CGC vs JPM vs TLRY vs ACB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FLGCFlora Growth Corp.
FY 2021
Pharmaceuticals and Nutraceuticals
100.0%$2M
CGCCanopy Growth Corporation
FY 2025
Other Revenue
0.0%$0
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
TLRYTilray Brands, Inc.
FY 2025
Cannabis Segment
36.1%$331M
Distribution Revenue
29.6%$271M
Beverage Alcohol Business
27.7%$253M
Wellness Business
6.6%$60M
ACBAurora Cannabis Inc.

Segment breakdown not available.

FLGC vs CGC vs JPM vs TLRY vs ACB — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGACB

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 4 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 19334.6x FLGC's $14M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to FLGC's -8.3%. On growth, CGC holds the edge at +9.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…
RevenueTrailing 12 months$14M$312M$280.3B$1.2B$311M
EBITDAEarnings before interest/tax-$4M-$63M$81.4B-$3.0B$14M
Net IncomeAfter-tax profit-$120M-$367M$57.0B-$2.9B-$75M
Free Cash FlowCash after capex-$9M-$77M$100.9B-$94M-$36M
Gross MarginGross profit ÷ Revenue+43.3%+24.9%+60.0%+28.0%+56.6%
Operating MarginEBIT ÷ Revenue-30.7%-33.0%+25.9%-2.7%+0.3%
Net MarginNet income ÷ Revenue-8.3%-117.4%+20.4%-2.5%-24.1%
FCF MarginFCF ÷ Revenue-63.5%-24.6%+36.0%-8.1%-11.6%
Rev. Growth (YoY)Latest quarter vs prior year-2.6%+9.6%+3.0%-57.9%
EPS Growth (YoY)Latest quarter vs prior year+2.6%+72.0%+16.0%+70.7%-125.0%
JPM leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

TLRY leads this category, winning 2 of 3 comparable metrics.
MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…
Market CapShares × price$88M$372M$908.6B$551M$181M
Enterprise ValueMkt cap + debt − cash$87M$243M$1.51T$698M$118M
Trailing P/EPrice ÷ TTM EPS-5.55x-1.55x16.22x-0.14x-1.92x
Forward P/EPrice ÷ next-FY EPS est.14.60x
PEG RatioP/E ÷ EPS growth rate0.92x
EV / EBITDAEnterprise value multiple18.52x
Price / SalesMarket cap ÷ Revenue1.49x1.09x3.25x0.49x0.80x
Price / BookPrice ÷ Book value/share19.61x4.18x2.51x0.21x0.46x
Price / FCFMarket cap ÷ FCF9.01x
TLRY leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

JPM leads this category, winning 6 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-3 for FLGC. ACB carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CGC scores 5/9 vs FLGC's 3/9, reflecting solid financial health.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…
ROE (TTM)Return on equity-3.3%-49.5%+15.9%-136.5%-13.4%
ROA (TTM)Return on assets-192.1%-31.8%+1.3%-100.6%-10.1%
ROICReturn on invested capital-5.5%-16.0%+4.5%-66.2%-25.8%
ROCEReturn on capital employed-6.9%-15.0%+8.9%-78.1%-25.6%
Piotroski ScoreFundamental quality 0–935544
Debt / EquityFinancial leverage0.76x0.33x2.60x0.22x0.05x
Net DebtTotal debt minus cash$48M-$183M$599.0B$147M-$89M
Cash & Equiv.Liquid assets$6M$509M$343.3B$304M$113M
Total DebtShort + long-term debt$54M$325M$942.4B$451M$24M
Interest CoverageEBIT ÷ Interest expense-18.87x-5.99x0.74x-89.43x-1.30x
JPM leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TLRY leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $25 for FLGC. Over the past 12 months, TLRY leads with a +1134.0% total return vs FLGC's -74.3%. The 3-year compound annual growth rate (CAGR) favors TLRY at 45.0% vs FLGC's -62.9% — a key indicator of consistent wealth creation.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…
YTD ReturnYear-to-date+5.3%-18.7%+0.8%-51.3%-32.5%
1-Year ReturnPast 12 months-74.3%-25.0%+20.9%+1134.0%-37.4%
3-Year ReturnCumulative with dividends-94.9%-84.0%+138.8%+205.2%-47.7%
5-Year ReturnCumulative with dividends-99.8%-99.6%+135.5%-72.0%-96.6%
10-Year ReturnCumulative with dividends-99.8%-95.4%+481.2%-78.9%-93.4%
CAGR (3Y)Annualised 3-year return-62.9%-45.7%+33.7%+45.0%-19.4%
TLRY leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

JPM leads this category, winning 2 of 2 comparable metrics.

JPM is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than FLGC's 3.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs FLGC's 15.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…
Beta (5Y)Sensitivity to S&P 5003.12x1.74x0.87x1.93x1.64x
52-Week HighHighest price in past year$47.00$2.38$338.09$15.70$6.67
52-Week LowLowest price in past year$5.86$0.84$269.72$0.35$2.73
% of 52W HighCurrent price vs 52-week peak+15.3%+40.6%+96.2%+30.1%+43.9%
RSI (14)Momentum oscillator 0–10047.133.272.133.831.8
Avg Volume (50D)Average daily shares traded11K10.1M7.4M4.9M1.1M
JPM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

JPM leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CGC as "Hold", JPM as "Buy", TLRY as "Hold", ACB as "Hold". Consensus price targets imply 1396.1% upside for CGC (target: $14) vs 4.5% for JPM (target: $340). JPM is the only dividend payer here at 1.83% yield — a key consideration for income-focused portfolios.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…
Analyst RatingConsensus buy/hold/sellHoldBuyHoldHold
Price TargetConsensus 12-month target$14.47$339.75$10.00$5.92
# AnalystsCovering analysts26612014
Dividend YieldAnnual dividend ÷ price+1.8%
Dividend StreakConsecutive years of raises0150
Dividend / ShareAnnual DPS$5.95
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+3.8%0.0%0.0%
JPM leads this category, winning 1 of 1 comparable metric.
Key Takeaway

JPM leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TLRY leads in 2 (Valuation Metrics, Total Returns).

Best OverallJPMorgan Chase & Co. (JPM)Leads 4 of 6 categories
Loading custom metrics...

FLGC vs CGC vs JPM vs TLRY vs ACB: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is FLGC or CGC or JPM or TLRY or ACB a better buy right now?

For growth investors, Canopy Growth Corporation (CGC) is the stronger pick with 79.

8% revenue growth year-over-year, versus -75. 6% for Flora Growth Corp. (FLGC). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — FLGC or CGC or JPM or TLRY or ACB?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -99. 8% for Flora Growth Corp. (FLGC). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FLGC's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — FLGC or CGC or JPM or TLRY or ACB?

By beta (market sensitivity over 5 years), JPMorgan Chase & Co.

(JPM) is the lower-risk stock at 0. 87β versus Flora Growth Corp. 's 3. 12β — meaning FLGC is approximately 259% more volatile than JPM relative to the S&P 500. On balance sheet safety, Aurora Cannabis Inc. (ACB) carries a lower debt/equity ratio of 5% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

04

Which is growing faster — FLGC or CGC or JPM or TLRY or ACB?

By revenue growth (latest reported year), Canopy Growth Corporation (CGC) is pulling ahead at 79.

8% versus -75. 6% for Flora Growth Corp. (FLGC). On earnings-per-share growth, the picture is similar: Flora Growth Corp. grew EPS 100. 0% year-over-year, compared to -76. 4% for Aurora Cannabis Inc.. Over a 3-year CAGR, CGC leads at 13. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — FLGC or CGC or JPM or TLRY or ACB?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -266. 3% for Tilray Brands, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -277. 9% for TLRY. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is FLGC or CGC or JPM or TLRY or ACB more undervalued right now?

Analyst consensus price targets imply the most upside for CGC: 1396.

1% to $14. 47.

07

Which pays a better dividend — FLGC or CGC or JPM or TLRY or ACB?

In this comparison, JPM (1.

8% yield) pays a dividend. FLGC, CGC, TLRY, ACB do not pay a meaningful dividend and should not be held primarily for income.

08

Is FLGC or CGC or JPM or TLRY or ACB better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 8% yield, +481. 2% 10Y return). Flora Growth Corp. (FLGC) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +481. 2%, FLGC: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between FLGC and CGC and JPM and TLRY and ACB?

These companies operate in different sectors (FLGC (Healthcare) and CGC (Healthcare) and JPM (Financial Services) and TLRY (Healthcare) and ACB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FLGC is a small-cap quality compounder stock; CGC is a small-cap high-growth stock; JPM is a large-cap deep-value stock; TLRY is a small-cap quality compounder stock; ACB is a small-cap quality compounder stock. JPM pays a dividend while FLGC, CGC, TLRY, ACB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.